Skip to main content
SpringerLink
Log in

Radiomic biomarkers for head and neck squamous cell carcinoma

  • Review Article
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Tumor heterogeneity is a well-known prognostic factor in head and neck squamous cell carcinoma (HNSCC). A major limitation of tissue- and blood-derived tumor markers is the lack of spatial resolution to image tumor heterogeneity. Tissue markers derived from tumor biopsies usually represent only a small tumor subregion at a single timepoint and are therefore often not representative of the tumors’ biology or the biological alterations during and after treatment. Similarly, liquid biopsies give an overall picture of the tumors’ secreted factors but completely lack any spatial resolution. Radiomics has the potential to give complete three-dimensional information about the tumor. We conducted a comprehensive literature search to assess the correlation of radiomics to tumor biology and treatment outcome in HNSCC and to assess current limitations of the radiomic biomarkers. In total, 25 studies that explored the ability of radiomics to predict tumor biology and phenotype in HNSCC and 28 studies that explored radiomics to predict post-treatment events were identified. Out of these 53 studies, only three failed to show a significant correlation. The major technical challenges are currently artifacts due to metal implants, non-standardized contrast injection, and delineation uncertainties. All studies to date were retrospective and none of the above-mentioned radiomics signatures have been validated in an independent cohort using an independent software implementation, which shows that transferability due to the numerous technical challenges is currently a major limitation. However, radiomics is a very young field and these studies hopefully pave the way for clinical implementation of radiomics for HNSCC in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Simard EP, Torre LA, Jemal A (2014) International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 50:387–403

    Article  PubMed  Google Scholar 

  2. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L, Group EW (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE‑5 population-based study. Eur J Cancer 51:2130–2143

    Article  PubMed  Google Scholar 

  4. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortes ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jackson SE, Chester JD (2015) Personalised cancer medicine. Int J Cancer 137:262–266

    Article  PubMed  Google Scholar 

  6. Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110:803–811

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35

    Article  PubMed  PubMed Central  Google Scholar 

  8. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–163

    Article  PubMed  Google Scholar 

  9. Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201

    Article  PubMed  Google Scholar 

  10. Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J, PET-NECK Trial Management Group (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444–1454

    Article  PubMed  Google Scholar 

  11. Combes JD, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50:370–379

    Article  PubMed  Google Scholar 

  12. Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 18:40

    Article  PubMed  Google Scholar 

  13. Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32:3365–3373

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rodel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, von Neubeck C, Baretton GB, Lock S, Thames HD, Krause M, Baumann M, DKTK-ROG (2014) HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 113:317–323

    Article  PubMed  Google Scholar 

  15. Bersani C, Mints M, Tertipis N, Haeggblom L, Sivars L, Ahrlund-Richter A, Vlastos A, Smedberg C, Grun N, Munck-Wikland E, Nasman A, Ramqvist T, Dalianis T (2017) A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer. Oral Oncol 68:53–59

    Article  PubMed  Google Scholar 

  16. Balermpas P, Rodel F, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Sak A, Stuschke M, Gkika E, Grosu AL, Abdollahi A, Debus J, Stangl S, Ganswindt U, Belka C, Pigorsch S, Multhoff G, Combs SE, Welz S, Zips D, Lim SY, Rodel C, Fokas E, DKTK-ROG (2017) The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG). Int J Cancer 141:594–603

    Article  PubMed  Google Scholar 

  17. Cohen EEW, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ, KEYNOTE-040 investigators (2019) Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 393:156–167

    Article  PubMed  Google Scholar 

  18. Tinhofer I, Stenzinger A, Eder T, Konschak R, Niehr F, Endris V, Distel L, Hautmann MG, Mandic R, Stromberger C, Weichert W, Budach V (2016) Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation. Ann Oncol 27:2262–2268

    Article  PubMed  Google Scholar 

  19. Eder T, Hess AK, Konschak R, Stromberger C, Johrens K, Fleischer V, Hummel M, Balermpas P, von der Grun J, Linge A, Lohaus F, Krause M, Baumann M, Stuschke M, Zips D, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Budach V, Tinhofer I, DKTK-ROG (2019) Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German cancer consortium radiation oncology group. Eur J Cancer 116:67–76

    Article  PubMed  Google Scholar 

  20. Linge A, Lohaus F, Lock S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jutz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rodel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M, DKTK-ROG (2016) HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German cancer consortium radiation oncology group (DKTK-ROG). Radiother Oncol 121:364–373

    Article  PubMed  Google Scholar 

  21. Hess AK, Johrens K, Zakarneh A, Balermpas P, Von Der Grün J, Rodel C, Weichert W, Hummel M, Keilholz U, Budach V, Tinhofer I (2019) Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas. OncoImmunology 8:1614858

    Article  PubMed  PubMed Central  Google Scholar 

  22. Budach V, Tinhofer I (2019) Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol 20:e313–e326

    Article  PubMed  Google Scholar 

  23. Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006

    Article  PubMed  Google Scholar 

  24. Leijenaar RT, Carvalho S, Hoebers FJ, Aerts HJ, van Elmpt WJ, Huang SH, Chan B, Waldron JN, O’Sullivan B, Lambin P (2015) External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 54:1423–1429

    Article  PubMed  Google Scholar 

  25. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38:285–289

    Article  PubMed  Google Scholar 

  26. Nordsmark M, Overgaard J (2004) Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43:396–403

    Article  PubMed  Google Scholar 

  27. Zschaeck S, Haase R, Abolmaali N, Perrin R, Stutzer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zophel K, Baumann M (2015) Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncol 54:1355–1363

    Article  PubMed  Google Scholar 

  28. Crispin-Ortuzar M, Apte A, Grkovski M, Oh JH, Lee NY, Schöder H, Humm JL, Deasy JO (2018) Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-fluorodeoxyglucose positron emission tomography radiomics features. Radiother Oncol 127:36–42

    Article  PubMed  Google Scholar 

  29. Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, Thorwarth D, Riess O, Zips D, Schroeder C, Welz S (2019) Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol 195:771–779

    Article  PubMed  Google Scholar 

  30. Raja JV, Khan M, Ramachandra VK, Al-Kadi O (2012) Texture analysis of CT images in the characterization of oral cancers involving buccal mucosa. Dentomaxillofac Radiol 41:475–480

    Article  PubMed  PubMed Central  Google Scholar 

  31. Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L, Nemec SF, Mueller-Mang C, Weber M, Mayerhoefer ME (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379

    Article  PubMed  Google Scholar 

  32. Brown AM, Nagala S, McLean MA, Lu Y, Scoffings D, Apte A, Gonen M, Stambuk HE, Shaha AR, Tuttle RM, Deasy JO, Priest AN, Jani P, Shukla-Dave A, Griffiths J (2016) Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med 75:1708–1716

    Article  PubMed  Google Scholar 

  33. Park M, Kim J, Choi YS, Lee SK, Koh YW, Kim SH, Choi EC (2016) Application of dynamic contrast-enhanced MRI parameters for differentiating squamous cell carcinoma and malignant lymphoma of the oropharynx. AJR Am J Roentgenol 206:401–407

    Article  PubMed  Google Scholar 

  34. Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors—is it possible to discriminate between benign and malignant masses in a multicenter trial? Fortschr Röntgenstr 188:195–202

    CAS  Google Scholar 

  35. Ramkumar S, Ranjbar S, Ning S, Lal D, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2017) MRI-based texture analysis to differentiate sinonasal squamous cell carcinoma from inverted papilloma. AJNR Am J Neuroradiol 38:1019–1025

    Article  PubMed  PubMed Central  Google Scholar 

  36. Yu H, Caldwell C, Mah K, Mozeg D (2009) Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging 28:374–383

    Article  PubMed  Google Scholar 

  37. Yu H, Caldwell C, Mah K, Poon I, Balogh J, MacKenzie R, Khaouam N, Tirona R (2009) Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys 75:618–625

    Article  PubMed  Google Scholar 

  38. Wu B, Khong P‑L, Chan T (2012) Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine. Int J Comput Assist Radiol Surg 7:635–646

    Article  PubMed  Google Scholar 

  39. Parmar C, Leijenaar RTH, Grossmann P, Rios Velazquez E, Bussink J, Rietveld D, Rietbergen MM, Haibe-Kains B, Lambin P, Aerts HJWL (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044–11044

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ren J, Tian J, Yuan Y, Dong D, Li X, Shi Y, Tao X (2018) Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I–II and III–IV head and neck squamous cell carcinoma. Eur J Radiol 106:1–6

    Article  PubMed  Google Scholar 

  41. Liao KY‑K, Chiu C‑C, Chiang W‑C, Chiou Y‑R, Zhang G, Yang S‑N, Huang T‑C (2019) Radiomics features analysis of PET images in oropharyngeal and hypopharyngeal cancer. Medicine 98:e15446–e15446

    Article  PubMed  PubMed Central  Google Scholar 

  42. Buch K, Fujita A, Li B, Kawashima Y, Qureshi MM, Sakai O (2015) Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am J Neuroradiol 36:1343–1348

    Article  PubMed  PubMed Central  Google Scholar 

  43. Fujita A, Buch K, Li B, Kawashima Y, Qureshi MM, Sakai O (2016) Difference between HPV-positive and HPV-negative non-oropharyngeal head and neck cancer: texture analysis features on CT. J Comput Assist Tomogr 40:43–47

    Article  PubMed  Google Scholar 

  44. Bogowicz M, Riesterer O, Ikenberg K, Stieb S, Moch H, Studer G, Guckenberger M, Tanadini-Lang S (2017) Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 99:921–928

    Article  PubMed  Google Scholar 

  45. Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O’Sullivan B, Rietveld D (2018) Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. Br J Radiol 91:20170498

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ranjbar S, Ning S, Zwart CM, Wood CP, Weindling SM, Wu T, Mitchell JR, Li J, Hoxworth JM (2018) Computed tomography-based texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinoma. J Comput Assist Tomogr 42:299–305

    Article  PubMed  Google Scholar 

  47. Huang C, Cintra M, Brennan K, Zhou M, Colevas AD, Fischbein N, Zhu S, Gevaert O (2019) Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes. EBioMedicine 45:70–80

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD (2019) Imaging-genomic study of head and neck squamous cell carcinoma: associations between radiomic phenotypes and genomic mechanisms via integration of the cancer genome atlas and the cancer imaging archive. JCO Clin Cancer Inform 3:1–9

    Article  PubMed  Google Scholar 

  49. Chen R‑Y, Lin Y‑C, Shen W‑C, Hsieh T‑C, Yen K‑Y, Chen S‑W, Kao C‑H (2018) Associations of tumor PD‑1 ligands, immunohistochemical studies, and textural features in (18)F-FDG PET in squamous cell carcinoma of the head and neck. Sci Rep 8:105–105

    Article  PubMed  PubMed Central  Google Scholar 

  50. Meyer H‑J, Schob S, Höhn AK, Surov A (2017) MRI texture analysis reflects histopathology parameters in thyroid cancer—a first preliminary study. Transl Oncol 10:911–916

    Article  PubMed  PubMed Central  Google Scholar 

  51. Dang M, Lysack JT, Wu T, Matthews TW, Chandarana SP, Brockton NT, Bose P, Bansal G, Cheng H, Mitchell JR, Dort JC (2015) MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 36:166–170

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ulrich EJ, Menda Y, Boles Ponto LL, Anderson CM, Smith BJ, Sunderland JJ, Graham MM, Buatti JM, Beichel RR (2019) FLT PET radiomics for response prediction to chemoradiation therapy in head and neck squamous cell cancer. Tomography 5:161–169

    Article  PubMed  PubMed Central  Google Scholar 

  53. Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J (2019) Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT-and PET-imaged head and neck cancer patients. PLoS ONE 14:e222509

    Article  PubMed  PubMed Central  Google Scholar 

  54. Zhai T‑T, Langendijk JA, van Dijk LV, Halmos GB, Witjes MJ, Oosting SF, Noordzij W, Sijtsema NM, Steenbakkers RJHM (2019) The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-) radiation. Oral Oncol 95:178–186

    Article  PubMed  Google Scholar 

  55. Yuan Y, Ren J, Shi Y, Tao X (2019) MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2019.06.019

    Article  PubMed  Google Scholar 

  56. Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RT, Garberis I, Gorphe P, Bidault F, Ferté C (2017) Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to human papillomavirus status. Oral Oncol 71:150–155

    Article  PubMed  Google Scholar 

  57. Beaumont J, Acosta O, Devillers A, Palard-Novello X, Chajon E, de Crevoisier R, Castelli J (2019) Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers. EJNMMI Res 9:90

    Article  PubMed  PubMed Central  Google Scholar 

  58. Diamant A, Chatterjee A, Vallières M, Shenouda G, Seuntjens J (2019) Deep learning in head & neck cancer outcome prediction. Sci Rep 9:2764

    Article  PubMed  PubMed Central  Google Scholar 

  59. Bogowicz M, Tanadini-Lang S, Veit-Haibach P, Pruschy M, Bender S, Sharma A, Hüllner M, Studer G, Stieb S, Hemmatazad H (2019) Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma. Acta Oncol 58(10):1514–1518. https://doi.org/10.1080/0284186X.2019.1629013

    Article  PubMed  CAS  Google Scholar 

  60. M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group (2018) Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients. Sci Rep. https://doi.org/10.1038/s41598-017-14687-0

    Article  Google Scholar 

  61. Cozzi L, Franzese C, Fogliata A, Franceschini D, Navarria P, Tomatis S, Scorsetti M (2019) Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics. Strahlenther Onkol 195:1–14

    Article  Google Scholar 

  62. Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP (2019) Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma. Eur J Radiol 110:1–6

    Article  PubMed  Google Scholar 

  63. Bogowicz M, Tanadini-Lang S, Guckenberger M, Riesterer O (2019) Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer. Sci Rep. https://doi.org/10.1038/s41598-019-51599-7

    Article  PubMed  PubMed Central  Google Scholar 

  64. Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V (2017) A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 7:13206

    Article  PubMed  PubMed Central  Google Scholar 

  65. Vallières M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts HJ, Khaouam N, Nguyen-Tan PF, Wang C‑S, Sultanem K (2017) Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep 7:10117

    Article  PubMed  PubMed Central  Google Scholar 

  66. Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T, Sunderland JJ, Graham MM, Buatti JM (2019) FDG PET based prediction of response in head and neck cancer treatment: assessment of new quantitative imaging features. PLoS ONE 14:e215465

    Article  PubMed  PubMed Central  Google Scholar 

  67. Bogowicz M, Riesterer O, Stark LS, Studer G, Unkelbach J, Guckenberger M, Tanadini-Lang S (2017) Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncol 56:1531–1536

    Article  PubMed  Google Scholar 

  68. Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, Unkelbach J, Guckenberger M, Konukoglu E, Lambin P (2017) Post-radiochemotherapy PET radiomics in head and neck cancer—the influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol 125:385–391

    Article  PubMed  Google Scholar 

  69. Liu Y, Shi H, Huang S, Chen X, Zhou H, Chang H, Xia Y, Wang G, Yang X (2019) Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images. Quant Imaging Med Surg 9:1288

    Article  PubMed  PubMed Central  Google Scholar 

  70. Sheikh K, Lee SH, Cheng Z, Lakshminarayanan P, Peng L, Han P, McNutt TR, Quon H, Lee J (2019) Predicting acute radiation induced xerostomia in head and neck cancer using MR and CT Radiomics of parotid and submandibular glands. Radiat Oncol 14:131

    Article  PubMed  PubMed Central  Google Scholar 

  71. Gabryś HS, Buettner F, Sterzing F, Hauswald H, Bangert M (2018) Design and selection of machine learning methods using radiomics and dosiomics for normal tissue complication probability modeling of xerostomia. Front Oncol 8:35

    Article  PubMed  PubMed Central  Google Scholar 

  72. Pota M, Scalco E, Sanguineti G, Farneti A, Cattaneo GM, Rizzo G, Esposito M (2017) Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification. Artif Intell Med 81:41–53

    Article  PubMed  Google Scholar 

  73. van Dijk LV, Thor M, Steenbakkers RJ, Apte A, Zhai T‑T, Borra R, Noordzij W, Estilo C, Lee N, Langendijk JA (2018) Parotid gland fat related magnetic resonance image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 128:459–466

    Article  PubMed  PubMed Central  Google Scholar 

  74. van Dijk LV, Noordzij W, Brouwer CL, Boellaard R, Burgerhof JG, Langendijk JA, Sijtsema NM, Steenbakkers RJHM (2018) 18F‑FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol 126:89–95

    Article  PubMed  Google Scholar 

  75. Cheng Z, Nakatsugawa M, Zhou XC, Hu C, Greco S, Kiess A, Page B, Alcorn S, Haller J, Utsunomiya K (2019) Utility of a clinical decision support system in weight loss prediction after head and neck cancer radiotherapy. JCO Clin Cancer Inform 3:1–11

    PubMed  Google Scholar 

  76. Abdollahi H, Mostafaei S, Cheraghi S, Shiri I, Mahdavi SR, Kazemnejad A (2018) Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: a machine learning and multi-variable modelling study. Phys Med 45:192–197

    Article  PubMed  Google Scholar 

  77. Thor M, Tyagi N, Hatzoglou V, Apte A, Saleh Z, Riaz N, Lee NY, Deasy JO (2017) A magnetic resonance imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer. Phys Imaging Radiat Oncol 1:34–40

    Article  PubMed  Google Scholar 

  78. He L, Huang Y, Ma Z, Liang C, Liang C, Liu Z (2016) Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep 6:34921

    Article  PubMed  PubMed Central  Google Scholar 

  79. Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H (2018) Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph 69:134–139

    Article  PubMed  PubMed Central  Google Scholar 

  80. Wei L, Rosen B, Vallières M, Chotchutipan T, Mierzwa M, Eisbruch A, El Naqa I (2019) Automatic recognition and analysis of metal streak artifacts in head and neck computed tomography for radiomics modeling. Phys Imaging Radiat Oncol 10:49–54

    Article  PubMed  PubMed Central  Google Scholar 

  81. Feldhaus F, Böning G, Jonczyk M, Kahn J, Fehrenbach U, Maurer M, Renz D, Hamm B, Streitparth F (2019) Metallic dental artifact reduction in computed tomography (smart MAR): improvement of image quality and diagnostic confidence in patients with suspected head and neck pathology and oral implants. Eur J Radiol 118:153–160

    Article  PubMed  Google Scholar 

  82. Hagen M, Kretschmer M, Würschmidt F, Gauer T, Giro C, Karsten E, Lorenzen J (2019) Clinical relevance of metal artefact reduction in computed tomography (iMAR) in the pelvic and head and neck region: multi-institutional contouring study of gross tumour volumes and organs at risk on clinical cases. J Med Imaging Radiat Oncol. https://doi.org/10.1111/1754-9485.12924

    Article  PubMed  Google Scholar 

  83. Hilgenfeld T, Prager M, Schwindling F, Nittka M, Rammelsberg P, Bendszus M, Heiland S, Juerchott A (2018) MSVAT-SPACE-STIR and SEMAC-STIR for reduction of metallic artifacts in 3T head and neck MRI. AJNR Am J Neuroradiol 39:1322–1329

    Article  PubMed  PubMed Central  Google Scholar 

  84. Pavic M, Bogowicz M, Wurms X, Glatz S, Finazzi T, Riesterer O, Roesch J, Rudofsky L, Friess M, Veit-Haibach P, Huellner M, Opitz I, Weder W, Frauenfelder T, Guckenberger M, Tanadini-Lang S (2018) Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol 57:1070–1074

    Article  PubMed  Google Scholar 

  85. Hatt M, Laurent B, Fayad H, Jaouen V, Visvikis D, Le Rest CC (2018) Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method. Eur J Nucl Med Mol Imaging 45:630–641

    Article  PubMed  Google Scholar 

  86. Mohamed AS, Hansen C, Weygand J, Ding Y, Frank SJ, Rosenthal DI, Hwang K‑P, Hazle JD, Fuller CD, Wang J (2017) Prospective analysis of in vivo landmark point-based MRI geometric distortion in head and neck cancer patients scanned in immobilized radiation treatment position: results of a prospective quality assurance protocol. Clin Transl Radiat Oncol 7:13–19

    Article  Google Scholar 

  87. Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O’Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, Gazzani SE, Calareso G, Scheckenbach K, Hoebers F, Wesseling FWR, Keek S, Sanduleanu S, Leijenaar RTH, Vergeer MR, Leemans CR, Terhaard CHJ, van den Brekel MWM, Hamming-Vrieze O, van der Heijden MA, Elhalawani HM, Fuller CD, Guckenberger M, Lambin P (2020) Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Sci Rep 10:4542

    Article  PubMed  PubMed Central  Google Scholar 

  88. O’Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14:169–186

    Article  PubMed  Google Scholar 

Download references

Funding

This Research was funded by SPHN IIMAGINE and CRPP Artificial Intelligence in Oncological Imaging.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistraße 100, 8091, Zurich, Switzerland

    Stephanie Tanadini-Lang, Panagiotis Balermpas, Matthias Guckenberger, Matea Pavic, Diem Vuong & Marta Bogowicz

  2. Centre for Radiation Oncology KSA-KSB, Canton Hospital Aarau, Aarau, Switzerland

    Oliver Riesterer

Authors
  1. Stephanie Tanadini-Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Panagiotis Balermpas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthias Guckenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matea Pavic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Oliver Riesterer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Diem Vuong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marta Bogowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie Tanadini-Lang.

Ethics declarations

Conflict of interest

S. Tanadini-Lang, P. Balermpas,M. Guckenberger, M. Pavic, O. Riesterer, D. Vuong, and M. Bogowicz declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanadini-Lang, S., Balermpas, P., Guckenberger, M. et al. Radiomic biomarkers for head and neck squamous cell carcinoma. Strahlenther Onkol 196, 868–878 (2020). https://doi.org/10.1007/s00066-020-01638-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-020-01638-4

Keywords

Search

Navigation